| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.4M | — | -67.5% |
| SG&A Expense | $1.1M | — | -62.1% |
| Operating Income | -$3.5M | — | +66.0% |
| Net Income | -$3.5M | — | +65.2% |
| EPS (Basic) | -$0.06 | — | +64.7% |
| EPS (Diluted) | -$0.06 | — | +64.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $66.3M | -7.7% | -28.5% |
| Total Assets | $66.5M | -7.7% | -28.7% |
| Current Liabilities | $24.3M | -12.5% | +70.3% |
| Long-term Debt | $15.3M | +0.0% | +0.0% |
| Total Liabilities | $24.3M | -12.5% | -17.8% |
| Stockholders' Equity | $42.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.1M | — | +59.0% |
| Investing Cash Flow | $0 | — | -100.0% |
| Financing Cash Flow | $71K | — | -92.9% |
| -33.7% |